Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Translumina Therapeutics Pvt Ltd.

Clinical trials sponsored by Translumina Therapeutics Pvt Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New heart stent aims to cut blood thinner time, lower bleeding risk Results expected Jul 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New heart stent aims to cut blood thinner time, lower bleeding risk

Disease control Recruiting now

This study is tracking 2,000 heart disease patients who receive the VIVO ISAR stent, a drug-coated device that releases medication to keep arteries open. Participants will take blood thinners for three months or less after the procedure. Researchers are monitoring for heart attac…

Sponsor: Translumina Therapeutics Pvt Ltd. • Aim: Disease control

Last updated Jun 26, 2026 18:10 UTC